Precision BioSciences, Inc. (DTIL)
NASDAQ: DTIL · Real-Time Price · USD
7.43
+0.13 (1.78%)
At close: Aug 14, 2026, 4:00 PM EDT
7.44
0.00 (0.07%)
After-hours: Aug 14, 2026, 7:34 PM EDT

Precision BioSciences Revenue

Precision BioSciences had revenue of $45.06M in the twelve months ending June 30, 2026, up 3,472.96% year-over-year. In the year 2025, Precision BioSciences had annual revenue of $34.26M, down -50.12%.

Revenue (ttm)
$45.06M
Revenue Growth
+3,472.96%
P/S Ratio
4.55
Revenue / Employee
$672,463
Employees
67
Market Cap
205.08M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202534.26M-34.43M-50.12%
Dec 31, 202468.70M19.97M40.98%
Dec 31, 202348.73M23.63M94.15%
Dec 31, 202225.10M-90.43M-78.28%
Dec 31, 2021115.53M91.24M375.72%
Dec 31, 202024.29M2.05M9.20%
Dec 31, 201922.24M11.36M104.34%
Dec 31, 201810.88M4.40M67.84%
Dec 31, 20176.48M-531.00K-7.57%
Dec 31, 20167.02M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Invivyd58.37M
Voyager Therapeutics34.46M
Keros Therapeutics15.01M
Innate Pharma10.57M
Korro Bio2.38M
YD Bio510.36K
Revenue Rankings